Tissue-specific expression of the glycoprotein hormone a-subunit gene in pituitary gonadotropes relies on a gonadotrope-specific element (GSE), which binds an approximately 54-kilodalton protein termed GSE-binding protein 1 (GSEBi). We report here that GSEBl is the orphan nuclear receptor steroidogenic factor-l (SF-l), which has been shown to be a primary regulator of steroidogenic enzymes in the adrenal gland and gonadal tissues. GSEBI from ~uT3-1 pituitary gonadotrope cells and SF-1 from Y 1 adrenocortical cells and R2C testicular Leydig cells display identical binding properties with both the GSE and SF-1 elements. Antiserum specific to the SF-1 DNA-binding domain abolishes the binding of both GSEBl and SF-1 to both elements.
SF-1 mRNA is found in the mouse pituitary and in the aT3-1 cell line but not in other pituitary cell lines, consistent with the pattern of GSEBl-binding activity. The GSE element specifically enhances transcription in SF-Icontaining cells. The discovery that an orphan nuclear receptor regulates the expression of both the gonadotropin hormones in the pituitary and the steroidogenic enzymes in the gonad provides a potential molecular mechanism for coordinate control in reproductive function, perhaps through an as yet unidentified endocrine ligand for SF-l. (Molecular Endocrinology 8: 878-885, 1994) INTRODUCTION During development of the anterior pituitary, five endocrine cell types emerge in a specific temporal pattern. Each cell type is distinguished by the production of a specialized hormone (or hormones). The earliest hormone gene to be expressed is the a-subunit gene of the glycoprotein hormones (1). The family of heterodimerit glycoprotein hormones, FSH, LH and TSH are 0988-8809/94/0878-0885503.00/0 Molecular Endocrinology Copyright Q 1994 by The Endomne Scmety made in two of the five adult pituitary cell types. Gonadotropes produce LH and FSH, and thyrotropes produce TSH. This specific pattern requires the coordinate expression of the a-subunit gene, the product of which is common to all members of this family, and of a celltype-specific P-subunit gene, the product of which dimerizes with the a-subunit and provides hormonal specificity. Thus, while both the gonadotrope and thyrotrope cells express the a-subunit gene, only the gonadotropes express the LH p-and FSH P-subunit genes, and only the thyrotrope expresses the TSH 8-subunit gene.
Such coordinate expression is also seen in human placental trophoblasts, which express the common glycoprotein hormone a-subunit gene with the human CG @-subunit genes. Regulation of placenta-specific expression of the a-subunit gene has been extensively investigated by transfection of human placental trophoblast cell lines. Studies have identified roles for the CAMP-responsive element (CRE) binding protein (for review see 2) two members of the GATA family of transcription factors, 3a) , and the trophoblast-specific element binding protein (TSEB; 4-6). All of these elements are closely spaced in an 80-base pair (bp) placenta-specific enhancer located 180 bp upstream of the mRNA start site. TSEB also regulates the placental specificity of hCG ,&subunit gene 5 (5), perhaps coordinating the expression of the two subunits in placenta.
The proximal 1.8kilobase (kb) 5'-flanking DNA of the human a-subunit gene was shown to confer expression to the pituitaries of transgenic mice (7, 8) and to primary pituitary cells in culture (9). In each case, evidence was obtained indicating that expression from this fragment is limited to the gonadotrope lineage. However, detailed analyses awaited the development of gonadotrope and thyrotrope lineage cell lines. Using targeted tumorigenesis in transgenic mice, we generated multiple cell lines representing different developmental stages of these two cell types (8, 10; Alarid, E. T., J. J. Windle, D. B. Whyte, and P. L. Mellon, in preparation). In addition, we obtained a primitive thyrotrope cell line from a trans-SF-l in Pituitary Gonadotropes 879 plantable mouse tumor (11). In particular, studies using the early gonadotrope lineage cell line, aT3-1, have provided insight into the factors and mechanisms controlling a-subunit expression in gonadotrope lineage cells (8, 12, 13) .
Control of the cell-specific expression of the a-subunit gene in pituitary has been shown to differ from that in placenta. As in placental trophoblasts, regulation of the human a-subunit gene expression in cuT3-1 gonadotrope cells involves the CRE (8, 12, 13) and members of the GATA factor family (3a). However, the placental factor, TSEB, is absent from both gonadotrope and thyrotrope cell lines. Instead, studies in pituitary cells indicate the involvement of several regions upstream of the TSE (8, (12) (13) (14) (15) . Mutation of the sequence from -337 to -330 of the mouse gene reduces expression in both (YT~-1 and L~TSH cells (13) but this region seems to have little effect in TtT-97 thyrotrope tumor cells when deleted from the mouse gene (14) or in ~uT3-1 cells when deleted from the human gene (12). Other regions of the mouse gene also have been implicated in activity in thyrotropes (-480 to -417, -254 to -177, and -177 to -120) (14) and in gonadotropes (-445 to -438) (13). The most well characterized element is termed the gonadotrope-specific element (GSE), located in the human gene from -223 to -197 (12 (16, 18) . SF-l was first identified through its ability to bind to and coordinately regulate the expression of genes encoding enzymes in the corticosteroid biosynthetic pathway and was found only in adrenocortical tissues (19, 20) . Subsequently, SF-l was shown to bind to and regulate the rat aromatase gene, which catalyzes the conversion of androgens to estrogens, in gonadal tissues (21). We now extend the restricted tissue specificity of SF-1 activity to include the pituitary gonadotrope and suggest that a potential ligand of this orphan receptor might play a role in the coordinate regulation of seemingly disparate genes in different tissues.
RESULTS

SF-1 and GSEBl Display identical DNA-Binding Characteristics
We previously identified and purified a 54-kilodalton (kDa) protein (GSEBl) from (YT~-1 cells that binds specifically to the GSE (12). The GSE element contains the sequence TG(A/T)CC, which comprises a half-site for binding of certain members of the nuclear steroid hormone receptor superfamily (22, 23) . Figure 1 illustrates the sequence of this element and compares it with the known binding sites for several members of this superfamily. Such striking sequence similarity suggests that GSEBl may be related to members of this superfamily.
These nuclear receptors contain conserved zinc finger motifs in their DNA-binding domains (24). Simons et al. (25) have demonstrated that binding of the glucocorticoid receptor to its cognate DNA sequence is abolished by treatment with sodium arsenite, presumably through interaction with the vicinal dithiols that comprise the zinc fingers. We used these findings to test whether a functional zinc finger motif is necessary for DNA binding by GSEBl.
Gel mobility shift assays using cuT3-1 nuclear extract or bacterially synthesized glucocorticoid receptor DNA-binding domain (26) and oligonucleotide probes corresponding to the a-subunit GSE, a CRE, or a glucocorticoid response element (GRE) were conducted in the absence or presence of increasing concentrations of sodium arsenite (Fig. 2) . While the binding of CRE-binding proteins to the CRE was completely unaffected, binding of both glucocorticoid receptor and GSEBl to their respective DNA elements was readily abolished by increasing concentrations of sodium arsenite, suggesting that GSEBl uses zinc fingers in binding to DNA.
Members of the steroid receptor superfamily typically (28) and radiolabeled GRE oligonucleotide, aT3-1 nuclear extract, and radiolabeled CRE oligonucleotide, or (YT~-1 nuclear extract and radiolabeled GSE oligonucleotide were conducted in the absence of sodium arsenite or the presence of a final concentration of 1 or 10 mM sodium arsenite (25) as indicated, and analyzed in a gel mobility shift assay. The arrow indicates specific GSEBl binding, and the bracket indicates the shifted bands corresponding to specific glucocorticoid receptor binding. Unlike the intact glucocorticoid receptor, the bacterially expressed glucorticoid receptor DNA-binding domain protein fragment is capable of binding as a monomer and a dimer in vitro, because it lacks some dimerization domains. The discrete glucocorticoid receptor-specific band is the monomer binding to the GRE and the more slowly migrating, characteristically more diffuse band is the dimer form (26). The third, fastest migrating band is not contributed by the glucocorticoid receptor bacterial expression vector.
bind as dimers to DNA sequence elements comprising two or more direct or inverted half-sites (27). However, GSEBl requires little more than the half-site for binding in gel shifts. Furthermore, no additional half-site for binding of a steroid receptor-like factor can be identified within or near the a-subunit GSE in any mammalian gene examined.
Repeated attempts to demonstrate anything other than monomer binding by GSEBl were unsuccessful (data not shown). Wilson et al. (28) recently demonstrated the ability of the orphan receptors nerve growth factor induced-B (NGFI-B) and SF-l to bind their respective sites as monomers. The ability of SF-l to interact with its response element in this manner, its restricted tissue distribution, and its reported molecular size (52 kDa, essentially the same as GSEBl at 54 kDa) prompted us to examine whether GSEBl might be related or identical to SF-l. Oligonucleotides corresponding to the a-subunit GSE and to a strong SF-l -binding site found in the promoter of the cholesterol side-chain cleavage enzyme gene (29) were used as probes in gel mobility shift assays with nuclear extracts from (YT~-1 cells and from two SF-l -containing cell lines, Yl mouse adrenocortical cells and R2C rat Leydig cells (21, 30) . When complexed with Yl nuclear extracts, this particular SF-1 -binding site is known to exhibit a single shifted band corresponding to SF-l (29). A single major band of identical retarded mobility is seen with both probes and in all three extracts (Fig. 3) . The faint band of greater mobility seen with the (YT~-1 extract is a degradation product which retains DNA-binding activity and arises from multiple freeze/thaw cycles; this phenomenon also has been previously noted for .
If GSEBl and SF-1 recognize the same sequence, inclusion of either unlabeled GSE or SF-l oligonucleotide competitor should abolish binding to either probe in gel mobility shift assays. Figure 4 demonstrates that binding of GSEBl in aT3-1 extracts (Fig. 4A , lanes 1 and 7) is competed by the inclusion of unlabeled SF-l oligonucleotide (Fig. 4A, lane 4) , while the shifted band in Yl and R2C cell extracts produced with the SF-l oligonucleotide (Fig. 4 , B and C, lane 10) is readily abolished by the inclusion of unlabeled GSE oligonucleotide (Fig. 4 , B and C, lane 12) as competitor. To further characterize the binding affinities of the proteins found in the three extracts, mutations were introduced into the GSE oligonucleotide, and these mutant oligonucleotides were used as both probes and competitors in gel shift assays. Previously we had described a two- Identical Mobility Oligonucleotides corresponding to the GSE of the human (Ysubunit promoter (lanes 1, 3, and 5) or an SF-1 binding site (lanes 2, 4, and 6) were mixed with nuclear extracts prepared from aT3-1 (lanes 1 and 2) Yl (lanes 3 and 4) or R2C (lanes 5 and 6) and subjected to electrophoresis in a gel mobility shift assay. The large filled arrow marks the single shifted band seen in all lanes; the small open arrow marks the degradation product in aT3-1 cells, as discussed in the text. Mobility shift assays using nuclear extracts prepared from aT3-1, Y-l, and R2C cells (A, B, and C, respectively) were performed using as probes or competitors oligonucleotides representing the GSE, the SF-l binding site, or mutations to the GSE as described in the text. SF-l (GSE-minus) or a binding site with a theoretically enhanced affinity for SF-1 (GSE-plus). Figure 4A illustrates a gel shift experiment using these oligonucleotides and (uT3-1 extract. The major shifted band seen when using the wild type GSE as a probe (lanes 1 and 7) is diminished when GSE-minus is used as a probe (lane 8) while use of GSE-plus as a probe enhances the same band (lane 9). When the binding reaction using wild type GSE as a probe (lane 1) is challenged with unlabeled GSE, SF-l, or GSE-plus competitors (lanes 2,4, and 6, respectively), the shifted band is completely abolished. When the same binding reaction is challenged with the GSE-minus oligonucleotide, the shifted band is only slightly diminished (lane 5) and when challenged with the mGSE oligonucleotide, the shifted band is unaffected (lane 3). The identical experiment was then performed with nuclear extracts from Yl cells (Fig. 4B ) and R2C cells (Fig. 4C) ; the results are the same in each of the three experiments. When a series of binding reactions using the SF-1 oligonucleotide as a probe with either cuT3-1 or Yl extracts are challenged with the same panel of oligonucleotide competitors as in lanes l-6 (Fig. 4 , A-C), the same relative order of competitor affinity is observed (Fig. 4D) .
To confirm the identity of GSEBl as SF-l, we challenged the binding of GSEBI to the GSE with antiserum specific to the DNA-binding domain of SF-l (16) generously provided by Dr. K. L. Parker, Duke University, Durham, NC. Neither control antiserum nor the SF-lspecific antiserum affected the binding of cuT3-1 proteins to a CRE oligonucleotide, and while a control antiserum did not affect the binding of GSEBI from cuT3-1 extracts or SF-l from Yl extracts to the GSE oligonucleotide, the SF-1 -specific antiserum abolished the binding of these proteins from both extracts (Fig.  5) . Confirming that the faint band of greater mobility is a degradation product of SF-l, it also is abolished by the SF-l antiserum. To further demonstrate the specificity of the SF-l antiserum, we used two binding sites from the human steroid 21-hydroxylase gene, which have been shown to bind both SF-1 and either chicken ovalbumin upstream promoter (COUP) transcription factor (-210 of the 21 -hydroxylase gene; 19) or NGFI-B (-65 of the 21 -hydroxylase gene; 31) in nuclear extracts from Yl cells. In both cases, the shifted band of the greatest mobility among multiple shifted bands repre-(uT3-1 and Y-l were performed using the SF-l oligonucleotide as probe and the same competitors as seen in lanes l-6 in A-C. the adrenal cortex and the gonadal steroidogenic tissues, while expression of SF-1 was absent from several nonsteroidogenic tissues examined, including brain, heart, liver, lung, and spleen, and in several cell lines examined, including HeLa and GH3 somatolactotrope cells (20) . We used several methods in addition to the gel shifts described above to demonstrate that SF-l is expressed in ~uT3-1 pituitary gonadotrope cells. First, oligonucleotides corresponding to selected sites within the SF-l cDNA sequence were synthesized and used as primers in polymerase chain reactions, which used (wT3-1 cDNA as a template. All reactions successfully produced DNA fragments of the appropriate lengths, and sequencing of these fragments confirmed that each was derived from an authentic SF-l cDNA (data not shown). One of these fragments, corresponding to the middle of the SF-l cDNA and including sequences that encode the DNA-binding domain, was subcloned into a plasmid vector and used as a probe in Northern analysis to examine expression in a wide selection of mouse tissues (Fig. 6A) . Strong expression of SF-l is seen in both the adrenal cortex and the ovary, with a distinct but lower level of expression in the pituitary. In addition, very weak expression of SF-l is evident in the hypo-RNA samples from the indicated mouse tissues (A) or cell lines (B) were subjected to Northern analysis using an SF-l cDNA probe. A, A single band of 2.9 kb of strong intensity is seen in RNA samples from the adrenal cortex and the ovary, of moderate intensity in the pituitary, and of weak intensity in the hypothalamus.
B, A single band of 2.9 kb is seen only in RNA samples prepared from R2C, Yl , and aT3-1 cells.
thalamus, the significance of which is currently unknown.
The lower level of SF-l expression seen in the pituitary could be due to a smaller number of transcripts generated throughout the tissue, or to specific expression in a subset of cell types. To examine the expression of SF-l in the pituitary in greater depth, the same probe was used in Northern analysis of a variety of cell lines, including several of pituitary origin (Fig. 6B) . SF-l message was detected in mRNA from R2C, Yl , and (YT~-1 cells (lanes 1, 2, and 3, respectively) but was absent from all other pituitary lines examined, including a-TSH thyrotropic cells (11) (lane 4) AtT-20 corticotropes (32) (lane 5) and GC somatolactotropes (33) (lane 6), as well as GTl-7 hypothalamic neurons (34) HeLa cells, and NIH3T3 fibroblasts (lanes 7-9) . A second, differently spliced mRNA is produced from the FTZ-Fl gene, which encodes the protein ELP (16). This mRNA has SF-1 in Pituitary Gonadotropes 883 been detected only in various undifferentiated embryonal carcinoma cell lines (16, 18) and is not found in any tissue from mouse embryonic stage 8 to adult (16). Using an ELP-specific cDNA fragment, we have not detected this mRNA in ~uT3-1 cells (data not shown).
The GSEBl/SF-1 Binding Site Enhances Transcription in Both Yl and aT3-1 Cells
While the experiments described above demonstrate that SF-l is able to bind to its cognate site found in the promoter of the a-subunit gene, they do not show that this GSE element is able to enhance gene transcription in an SF-l-dependent manner. To demonstrate such an ability, we added one or two copies of the human cysubunit gene GSE element to a reporter construct consisting of the herpes simplex virus thymidine kinase (TK) gene promoter fused to a chloramphenicol acetyltransferase (CAT) expression vector. We transfected these constructs into NIH3T3 cells, which do not contain SF-l, and into both (uT3-1 and Yl cells, which do contain SF-l (Fig. 7) . While addition of single or multiple copies of the GSE had no effect on transcription in NIH3T3 cells, such additions enhanced transcription in both (YT~-1 and Yl cells to similar levels, demonstrating the potential of the GSE element as an SF-l -dependent regulatory element. were transfected as described in Materials and Methods, with either the herpes simplex virus TK promoter on a CAT expression vector (TK-CAT) or the same vector containing one (GSE-TK-CAT) or two [(GSE)*-TK-CAT] copies of the GSE cloned upstream of the promoter (12) as indicated. Each determination represents the mean + SE of triplicate experiments. CAT activities are presented relative to that of the TK-CAT construct.
role, these hormones are necessary for the stimulation and maintenance of steroidogenesis and gametogenesis in the gonads. Thus, the binding of LH and FSH to their respective receptors in gonadal tissue prompts the production of progesterone and estradiol in the female and testosterone in the male by inducing the steroidogenic enzyme genes. While the discovery that SF-l, a primary regulator of steroid biosynthetic enzyme gene expression in gonadal and adrenocortical cells, also regulates the expression of the gonadotropin genes in the pituitary seems initially incongruous, the implication is presented that SF-l is a regulator of a comprehensive set of steroidogenic hormones in a more global regulatory pathway than was once imagined. SF-l is apparently able to stimulate the synthesis of not only corticosteroids such as glucocorticoids and aldosterone in the adrenal cortex and the production of estrogens and androgens in the ovary and testis by activating the expression of the enzymes that synthesize precursors to these hormones (such as cholesterol side-chain cleavage enzyme; 29) and by increasing the expression of aromatase (21), which conducts bioconversion of androgens to estrogens, but is also able to indirectly control the synthesis of primary steroid sex hormones by acting at the pituitary level to influence the expression of the gonadotropin hormone genes. The absence of SF-l in the corticotrope cell line AtT-20, which secretes ACTH, the predominant regulator of glucocorticoid biosynthesis in the adrenal cortex, tempts the speculation of a special role for SF-l in sex steroid regulation. However, the presence of functional SF-l -binding sites in the promoters of genes encoding terminal enzymes in steroid biosynthesis pathways divergent from sex steroid synthesis, such as 11 P-hydroxylase (19), and the apparent widespread expression of SF-l throughout the adrenal cortex (16) argue against this idea.
It will be intriguing to investigate the developmental pattern of SF-l expression in the pituitary, similar to studies of the pituitary factor Pit-l/GHF-1 (1). lkeda et al. (16) demonstrated that SF-1 expression was first detected in the mouse adrenal gland and testes at embryonic day 12. Because aT3-1 cells may represent early gonadotrope progenitors of approximately embryonic day 13 in pituitary development (8) SF-l expression in the gonadotrope may arise concurrently with expression in steroidogenic tissues. Because SF-l now has been shown to be expressed in three different tissue types, it cannot be the sole determinant of the tissue-specific expression of the (Ysubunit gene in gonadotropes.
As both we (12) and others (13) have shown, additional sites upstream of the GSE play a significant role in the expression of the a-subunit gene in the pituitary gonadotrope. Tissue specificity of such expression may be a result of the coordinate regulation by multiple factors binding to those sites, possibly in conjunction with SF-l.
The significance of finding that an orphan nuclear receptor protein regulates the expression of both steroidogenic and gonadotropin genes in the hypothalamo- MOL ENDO. 1994 884 Vol8 No. 7 pituitary-gonadal axis may lie with the potential ligand of SF-l, which could play an endocrine role in coordinating reproductive function. It will be of utmost importance to unravel the specific role of SF-l in this novel pathway of coordinate gene expression to further our understanding of the molecular control of reproduction. 
